Characteristic | Projects funded by AHRQ (N = 104) | Projects not funded by AHRQ (N = 48) | All projects (N = 152) | |||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Discipline | ||||||
Clinical | 97 | (93) | 47 | (98) | 144 | (95) |
Public health | 5 | (5) | 1 | (2) | 6 | (4) |
Toxicology | 2 | (2) | 0 | (0) | 2 | (1) |
Primary focus of the review | ||||||
Interventions (therapeutic or preventive) | 79 | (76) | 30 | (63) | 109 | (72) |
Diagnosis | 14 | (14) | 1 | (2) | 15 | (10) |
Epidemiology—exposure-outcome association | 0 | (0) | 10 | (21) | 10 | (7) |
Epidemiology—incidence or prevalence | 2 | (2) | 2 | (4) | 4 | (3) |
Prognosis | 1 | (1) | 0 | (0) | 1 | (1) |
Screening | 6 | (6) | 0 | (0) | 6 | (4) |
Methodology | 2 | (2) | 5 | (10) | 7 | (5) |
Primary health area addressed (per International Classification of Diseases-10) | ||||||
Mental and behavioral disorders | 30 | (29) | 1 | (2) | 31 | (20) |
Diseases of the eye and ocular adnexa | 1 | (1) | 22 | (46) | 23 | (15) |
Neoplasms | 11 | (11) | 2 | (4) | 13 | (9) |
Diseases of the musculoskeletal system and connective tissue | 11 | (11) | 1 | (2) | 12 | (8) |
Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified | 4 | (4) | 6 | (13) | 10 | (7) |
Diseases of the genitourinary system | 5 | (5) | 4 | (8) | 9 | (6) |
Diseases of the circulatory system | 7 | (7) | 1 | (2) | 8 | (5) |
Diseases of the respiratory system | 7 | (7) | 0 | (0) | 7 | (5) |
Certain infectious and parasitic diseases | 7 | (7) | 0 | (0) | 7 | (5) |
Factors influencing health status and contact with health services | 5 | (5) | 1 | (2) | 6 | (4) |
Injury, poisoning, and certain other consequences of external causes | 5 | (5) | 0 | (0) | 5 | (3) |
Endocrine, nutritional, and metabolic diseases | 2 | (2) | 2 | (4) | 4 | (3) |
Pregnancy, childbirth, and the puerperium | 3 | (3) | 1 | (2) | 4 | (3) |
Diseases of the digestive system | 2 | (2) | 1 | (2) | 3 | (2) |
Congenital malformations, deformations, and chromosomal abnormalities | 1 | (1) | 0 | (0) | 1 | (1) |
Diseases of the ear and mastoid process | 1 | (1) | 0 | (0) | 1 | (1) |
Codes for special purposes | 0 | (0) | 1 | (2) | 1 | (1) |
Other—methodology | 2 | (2) | 5 | (10) | 7 | (5) |
Type of project | ||||||
Full systematic review/technology assessment | 93 | (90) | 39 | (81) | 132 | (87) |
Technical brief | 8 | (8) | 0 | (0) | 8 | (5) |
Methods research | 2 | (2) | 5 | (10) | 7 | (5) |
Evidence map | 1 | (1) | 4 | (8) | 5 | (3) |
Registration status in PROSPERO (for full systematic reviews/technology assessments only) | ||||||
Yes | 46 | (49) | 12 | (31) | 48 | (44) |
No | 47 | (51) | 27 | (69) | 74 | (56) |
Funding source(s) for project (more than one funding source could apply) | ||||||
Government | 104 | (100) | 32 | (70) | 136 | (91) |
Pharmaceutical industry | 0 | (0) | 0 | (0) | 0 | (0) |
Other industry | 0 | (0) | 5 | (11) | 5 | (3) |
Foundation/professional society | 0 | (0) | 3 | (7) | 3 | (2) |
Other funding source | 0 | (0) | 11 | (24) | 11 | (7) |
Explicitly stated that no funding was received | 0 | (0) | 2 | (5) | 2 | (2) |
Country of corresponding author | ||||||
USA | 102 | (98) | 43 | (90) | 145 | (95) |
Canada | 2 | (2) | 0 | (0) | 2 | (1) |
UK | 0 | (0) | 2 | (4) | 2 | (1) |
Germany | 0 | (0) | 1 | (2) | 1 | (1) |
Lebanon | 0 | (0) | 1 | (2) | 1 | (1) |
Saudi Arabia | 0 | (0) | 1 | (2) | 1 | (1) |
Format of addition of included study data to SRDR (more than one format could apply) | ||||||
Manual completion of SRDR data extraction forms | 27 | (26) | 39 | (81) | 66 | (43) |
Import of data into SRDR data extraction forms | 23 | (22) | 19 | (40) | 42 | (28) |
Upload of data as flat files (i.e., not into SRDR data extraction forms) | 68 | (65) | 2 | (4) | 70 | (46) |